Aarti Pharmalabs

Aarti Pharmalabs Contract Manufacturing & Development (CDMO) Profile

Over the last two decades, Aarti Pharmalabs Limited serving global clients with top notch scientific knowledge, industry experts, state-of-the-art R&D and USFDA, EUGMP, EDQM, KFDA inspected manufacturing facilities. We offer CDMO services for small molecules drug substances (GMP API/NCE/KSM/RSM/GMP Intermediate) process development and manufacturing focusing on Ph-I/II/III, launch and commercial phase projects for Innovator Pharmaceutical and Biotech companies. We have been helping our clients to bring their molecules to market quickly and efficiently from clinical development through commercial stage manufacturing. We manufacture Generic APIs, Intermediates and Xanthine derivatives as well.

We have dedicated facilities to manufacture HPAPIs, Corticosteroids, Cytotoxic and Oncology products. We are one of the preferred partner for Beverages and Nutraceuticals Industries for our flagship product ‘Synthetic Caffeine’

CDMO Services:
API and/or Ingredients Analytical Development; ICH Stability Testing; Process Development

Year Founded: 1984

Head Office: Mumbai, India

Number of Facilities: 3-5

Facility locations: South Asia

Website: Visit the Aarti Pharmalabs website

Linkedin: Connect on Linkedin

Current Capacity: 1200 KL capacity with 350+ reactors (Kilo scale, Pilot and Commercial scale) for Small molecules Drug Substances and Peptides